Morepen Laboratories Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Morepen Laboratories.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 17.8% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump
Aug 20
Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)
Aug 09Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified
Jul 05Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?
Jun 13Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing
Apr 23Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly
Nov 23Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 22Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
Aug 10Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 21Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Apr 05Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?
Sep 14Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
May 21Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?
Mar 12Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay
Feb 22Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Feb 07Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain
Jan 21Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet
Jan 03
Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?
Dec 16Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Nov 28In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Morepen Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 17,748 | 1,313 | -436 | 483 | N/A |
| 6/30/2024 | 17,571 | 1,177 | N/A | N/A | N/A |
| 3/31/2024 | 17,019 | 962 | -80 | 734 | N/A |
| 12/31/2023 | 16,422 | 761 | N/A | N/A | N/A |
| 9/30/2023 | 15,433 | 531 | -15 | 625 | N/A |
| 6/30/2023 | 15,238 | 477 | N/A | N/A | N/A |
| 3/31/2023 | 14,220 | 387 | -1,371 | -912 | N/A |
| 12/31/2022 | 14,270 | 428 | N/A | N/A | N/A |
| 9/30/2022 | 14,765 | 553 | -2,443 | -1,950 | N/A |
| 6/30/2022 | 14,721 | 768 | N/A | N/A | N/A |
| 3/31/2022 | 15,558 | 1,017 | -1,276 | -602 | N/A |
| 12/31/2021 | 14,743 | 1,161 | N/A | N/A | N/A |
| 9/30/2021 | 13,854 | 1,184 | -213 | 520 | N/A |
| 6/30/2021 | 13,295 | 1,082 | N/A | N/A | N/A |
| 3/31/2021 | 11,980 | 971 | 104 | 508 | N/A |
| 12/31/2020 | 11,136 | 814 | N/A | N/A | N/A |
| 9/30/2020 | 10,380 | 684 | 258 | 389 | N/A |
| 6/30/2020 | 9,183 | 453 | N/A | N/A | N/A |
| 3/31/2020 | 8,584 | 336 | -60 | 110 | N/A |
| 12/31/2019 | 8,731 | 331 | N/A | N/A | N/A |
| 9/30/2019 | 8,530 | 312 | -218 | -38 | N/A |
| 6/30/2019 | 8,117 | 340 | N/A | N/A | N/A |
| 3/31/2019 | 7,714 | 288 | 55 | 174 | N/A |
| 12/31/2018 | 7,258 | 252 | N/A | N/A | N/A |
| 9/30/2018 | 6,672 | 267 | N/A | N/A | N/A |
| 6/30/2018 | 6,436 | 308 | N/A | N/A | N/A |
| 3/31/2018 | 6,101 | 296 | N/A | 634 | N/A |
| 3/31/2017 | 5,991 | 236 | N/A | 407 | N/A |
| 3/31/2016 | 4,861 | 128 | N/A | 501 | N/A |
| 3/31/2015 | 4,014 | 21 | N/A | 507 | N/A |
| 3/31/2014 | 3,670 | -28 | N/A | 335 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if MOREPENLAB's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if MOREPENLAB's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if MOREPENLAB's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if MOREPENLAB's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if MOREPENLAB's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MOREPENLAB's Return on Equity is forecast to be high in 3 years time